Boards Biochem Flashcards
Chromatin
- Core struture of H2 with H1 not in core octomer. Increased H1 leads to increased more heterochromatin
- Contains positively charged amino acids Arginine and lysine.
DNA Methylation
- Occurs on template strand during replication to C and A, contain ketone groups.
- Aids in mismatch repair
Histone Methylation
Shuts down transcription
Histone Acetylation
Increases Transcription
Nucleotide demethylation
C-U demethylation is possible mutation
Amino Acids Necessary for Nucleotide synthesis
-Glycine, Arginine, glutamate
Purine Synthesis overview
- Begins with ribose-5P from HMP shunt then add ATP to make PRPP.
- PRPP goes through a number of steps to generate IMP which can then be converted to AMP and GMP
Pyrimidine Synthesis Overview
- Begins with ribose-5P from HMP shunt then add ATP to make PRPP.
- PRPP added to orotic acid to generate UMP
- UMP converted to CTP
- UMP converted to dUMP through ribonucleotide reductase
- dUMP converted to dTMP through thymatidylate synthase and dihydrofolate reductase. (methyl group added)
6 Mercaptopurine
Blocks Purine Synthesis
-activated by HGPRT and other steps in de novo purine synthesis
Hydroxyurea
Blocks ribonucleotide reductase
-Inhibits synthesis of Uracil and Thymidine
TMP
-Blocks Dihydrofolate reductase (Specifically in bacteria)
SMX
-Blocks production of folate in bacteria (PABA)
5-FU
Blocks thymidylate synthase
Orotic Aciduria
Defect in UMP synthase in Pyrimidine Synthesis pathway
- Leads to accumulation of orotic acid and impaired pyrimidine synthesis
- Orotic Aciduria, Megaloblastic anemia that doesn’t correct with folate or B12, No changes in urea cycle. Autosomal recessive
- Tx: uridine summplementation
Ornithine Transcarbamoylase
XR mutation in ornithine transcarbamoylase. Normally converts ornithine and carbamoyl phosphate into citurline
- Defect leads to accumulation of carbamoyl phosphate which is converted to orotic acid.
- Symptoms: Orotic aciduria, no megaloblastic anemia, reduced BUN and increased ammonia.
- Liver transplant is currative, argenine supplementation (impaired urea cycle is arginine sink), low nitrogen diet
Purine Salvage Overview
- Adenosine is deaminated to inosine, GMP is converted to inosine for pool.
- Inosine and Guanine are converted to hypoxanthine, xanthine, and uric acid to be secreted.
Adenosine Deaminase Deficency
- AR, Impaired ability to deaminate adenosine and turn to inosine. Causes increase in adenine andadensoine that inhibits ribonucleotide reductase leading to impaired synthesis and death of Lymphocytes
- A major cause of SCID
- Can be treated with gene therapy
Lesch-Nyhan
- XR, defect in HGPRT. Normally HGPRT allows for hypoxanthine and guanine to feeback into inosine pool to be converted to Gaunosine and adenosine.
- Leads to impaired salvage, increased de novo production, and increased uric acid production
- Symptoms are Retardation, self mutilation, gout
Allopurinol
Inhibits xanthine oxidase. Conversion of Xanthine to Uric acid.
-Used to treat gout
Severity of mutations
-Silent<Frameshift
RNA Pol I
-rRNA, increased in nucleolus
RNA Pol 2
Binds to promote, AT rich region, and trancribes DNA
RNA Pol 3
Transcribes tRNA
Stop Codons
UAA, UGA, UAG
RNA processing
- Occurs in nucleus
- 5’ 7 methylguanine cap
- Polyadenalation
- Splicing out introns (snRNP)
SnRNP
Aid in splicing
-Can be a nidus for Lupus. Ab to DS DNA
Splicing Mutation Disease
Beta Thallesemia
tRNA Structure
Cloverleaf with many modified bases. AA binds to 3’ OH
-mRNA codon is read 5’ to 3’. tRNA anticodon is read 3’ to 5’
Charging
- Each tRNA is specific for a single AA. Determines the binding.
- Energy in tRNA-AA bond is enough to catalyze peptide bond formation
- ATP is the energy Source
Initiation of Protein Synthesis
Initiation factors bind ribosome and aid in assembly of ribosome and are released once mRNA binds.
Elongation
Charged tRNA binds to A site, and is moved to P site as the peptide bond is catalyzed by the ribosome
- tRNA leaves from the E site.
- GTP is the energy source for elongation
Termination
-Termiation signals involve releasing factors
Tetracyclines
- Bind 30 SPrevent binding of charged tRNA to acceptor site
Aminoglycosides
-Bind 30s and prevent initiation, Misreading leads to bacteriocidal activity
Macrolides
- Bind 50S and prevent tRNA from leaving the E site
- Bacteriostatic